81 related articles for article (PubMed ID: 20043116)
1. Identification of a 0.4 Kb deletion region in 10q26 associated with endometrial carcinoma.
Alves M; Carreira I; Liberato P; Ramos S; Mafra M; Inverno AS; Maia AT; Martins AP; Brito M; Monteiro C
Oncol Rep; 2010 Feb; 23(2):519-22. PubMed ID: 20043116
[TBL] [Abstract][Full Text] [Related]
2. Identification of a 790-kilobase region of common allelic loss in chromosome 10q25-q26 in human endometrial cancer.
Nagase S; Yamakawa H; Sato S; Yajima A; Horii A
Cancer Res; 1997 May; 57(9):1630-3. PubMed ID: 9134997
[TBL] [Abstract][Full Text] [Related]
3. Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers.
Peiffer SL; Herzog TJ; Tribune DJ; Mutch DG; Gersell DJ; Goodfellow PJ
Cancer Res; 1995 May; 55(9):1922-6. PubMed ID: 7728760
[TBL] [Abstract][Full Text] [Related]
4. Allelotype of endometrial carcinoma.
Fujino T; Risinger JI; Collins NK; Liu FS; Nishii H; Takahashi H; Westphal EM; Barrett JC; Sasaki H; Kohler MF
Cancer Res; 1994 Aug; 54(16):4294-8. PubMed ID: 8044774
[TBL] [Abstract][Full Text] [Related]
5. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q.
Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M
Genes Chromosomes Cancer; 2000 Mar; 27(3):244-51. PubMed ID: 10679913
[TBL] [Abstract][Full Text] [Related]
6. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
7. A 1-Mb bacterial clone contig spanning the endometrial cancer deletion region at 1p32-p33.
Arlt MF; Li M; Herzog TJ; Goodfellow PJ
Genomics; 1999 Apr; 57(1):62-9. PubMed ID: 10191084
[TBL] [Abstract][Full Text] [Related]
8. DCC genetic alterations and expression in endometrial carcinoma.
Ronnett BM; Burks RT; Cho KR; Hedrick L
Mod Pathol; 1997 Jan; 10(1):38-46. PubMed ID: 9021725
[TBL] [Abstract][Full Text] [Related]
9. Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer.
Huang H; Reed CP; Mordi A; Lomberk G; Wang L; Shridhar V; Hartmann L; Jenkins R; Smith DI
Genes Chromosomes Cancer; 1999 Jan; 24(1):48-55. PubMed ID: 9892108
[TBL] [Abstract][Full Text] [Related]
10. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma.
Grady B; Goharderakhshan R; Chang J; Ribeiro-Filho LA; Perinchery G; Franks J; Presti J; Carroll P; Dahiya R
J Urol; 2001 Sep; 166(3):1088-92. PubMed ID: 11490304
[TBL] [Abstract][Full Text] [Related]
11. A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers.
Castells A; Gusella JF; Ramesh V; Rustgi AK
Cancer Res; 2000 Jun; 60(11):2836-9. PubMed ID: 10850424
[TBL] [Abstract][Full Text] [Related]
12. Fine mapping of chromosome 10q deletions in mycosis fungoides and sezary syndrome: identification of two discrete regions of deletion at 10q23.33-24.1 and 10q24.33-25.1.
Wain EM; Mitchell TJ; Russell-Jones R; Whittaker SJ
Genes Chromosomes Cancer; 2005 Feb; 42(2):184-92. PubMed ID: 15540164
[TBL] [Abstract][Full Text] [Related]
13. Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q.
Bryan EJ; Watson RH; Davis M; Hitchcock A; Foulkes WD; Campbell IG
Cancer Res; 1996 Feb; 56(4):719-21. PubMed ID: 8631002
[TBL] [Abstract][Full Text] [Related]
14. Detailed deletion mapping on chromosome arm 12q in human pancreatic adenocarcinoma: identification of a I-cM region of common allelic loss.
Kimura M; Abe T; Sunamura M; Matsuno S; Horii A
Genes Chromosomes Cancer; 1996 Oct; 17(2):88-93. PubMed ID: 8913725
[TBL] [Abstract][Full Text] [Related]
15. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas.
Colitti CV; Rodabaugh KJ; Welch WR; Berkowitz RS; Mok SC
Oncogene; 1998 Jan; 16(4):555-9. PubMed ID: 9484846
[TBL] [Abstract][Full Text] [Related]
16. Mapping an endometrial cancer tumor suppressor gene at 10q25 and development of a bacterial clone contig for the consensus deletion interval.
Peiffer-Schneider S; Noonan FC; Mutch DG; Simpkins SB; Herzog T; Rader J; Elbendary A; Gersell DJ; Call K; Goodfellow PJ
Genomics; 1998 Aug; 52(1):9-16. PubMed ID: 9740666
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.
Rasheed BK; McLendon RE; Friedman HS; Friedman AH; Fuchs HE; Bigner DD; Bigner SH
Oncogene; 1995 Jun; 10(11):2243-6. PubMed ID: 7784070
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity of chromosome 3p sequences is an infrequent event in endometrial cancer.
Arlt MF; Herzog TJ; Mutch DG; Goodfellow PJ
Gynecol Oncol; 1996 Feb; 60(2):308-12. PubMed ID: 8631557
[TBL] [Abstract][Full Text] [Related]
19. Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1.
Yokota T; Yoshimoto M; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y; Emi M
Cancer; 1999 Jan; 85(2):447-52. PubMed ID: 10023714
[TBL] [Abstract][Full Text] [Related]
20. Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma.
Bandera CA; Takahashi H; Behbakht K; Liu PC; LiVolsi VA; Benjamin I; Morgan MA; King SA; Rubin SC; Boyd J
Cancer Res; 1997 Feb; 57(3):513-5. PubMed ID: 9012483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]